EAM Global Investors’s CytomX Therapeutics CTMX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q2
Sell
-48,575
Closed -$1.38M 160
2018
Q1
$1.38M Buy
+48,575
New +$1.38M 0.72% 37